期刊文献+

中低位直肠癌术前放化疗后原发瘤消退与淋巴结转移的关系 被引量:2

Association between primary tumor regression and lymph node status after neoadjuvant chemoradiotherapy in mid and low rectal cancer
原文传递
导出
摘要 目的探讨淋巴结转移情况与肿瘤消退在中低位直肠癌术前放化疗后的关系。方法回顾性分析2003年1月至2010年11月间北京军区总医院收治的71例局部进展期(T3~4NxM0)中低位直肠癌(肿瘤位于腹膜反折以下)患者的临床资料。对切除术后标本进行病理检查,了解淋巴结状态和原发肿瘤之间的关系。结果71例患者全部按计划完成术前放化疗,12例获得病理完全缓解,其中1例未行手术,予以随访观察。70例接受直肠癌根治术的患者术后病理示,39例原发肿瘤降至T0-2期,其中淋巴结转移5例(12.8%);31例原发肿瘤仍处于B。期,其中淋巴结转移10例(32.3%);两者比较差异有统计学意义(P=0.029)。结论中低位直肠癌术前放化疗后,肿瘤消退程度与淋巴结转移减少具有一致性。 Objective To analyze the association between the response of primary tumor to neoadjuvant chemoradiotherapy (CRT) and lymph node status in mid and low rectal cancer. Methods Seventy-one patients with locally advanced mid and low rectal cancer underwent preoperative CRT followed by surgery. Surgical specimens were examined by surgeons and pathologists to obtain more lymph nodes and the histological sections were examined. Tumor responses to preoperative CRT were assessed in terms of tumor downstaging and tumor regression. Statistical analyses were performed to investigate the relationship between tumor regression and lymph node status. Results All the patients completed the neoadjuvant CRT. Twelve patients achieved pathological complete response, of whom one was not operated and on surveillance. Pathological examination of the remaining 70 patients showed that the tumor was downstaged to T 0-2 group in 39 patients, among whom 5 patients (12.8%) had positive lymph nodes. Tumor was not downstaged in 31 patients, of whom 10 patients (32.3%) had positive nodes. The difference between the two groups was statistically significant (P=0.029). Conclusion Tumor regression is consistent with the reduction of lymph node metastasis after preoperative CRT.
出处 《中华胃肠外科杂志》 CAS 北大核心 2011年第12期961-963,共3页 Chinese Journal of Gastrointestinal Surgery
关键词 直肠肿瘤 淋巴结 化学疗法 放射疗法 肿瘤降期 Rectal neoplasms Lymph node Chemotherapy Radiotherapy Downstaging
  • 相关文献

参考文献9

  • 1Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med, 2006,355(11) : 1114-1119.
  • 2Leibold T, Shia J, Ruo L, et al. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol, 2008,26 (13) : 2106-2111.
  • 3Capirci C, Valentini V, Cionini L, et al. Prognostie value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients, lnt J Radiat Oncol Biol Phys, 2008,72( 1 ) : 99-107.
  • 4Losi L, Luppi G, Gavioli M, et al. Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy, lnt J Colorectal Dis, 2006,21(7) :646-651.
  • 5dBeddy D, Hyland JM, Winter DC, et al. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol, 2008,15 (12) : 3471-3477.
  • 6Kim NK, Kim M J, Park JK, et al. Preoperative staging of rectal cancer with MRl:accuracy and clinical usefulness. Ann Surg Oncol, 2000,7(10) :732-737.
  • 7Ptok H, Marusch F, Meyer F, et al. Feasibility and accuracy of TRUS in the pre-treatment staging for rectal carcinoma in general practice. Eur J Surg Oncol, 2006,32(4):420-425.
  • 8Read TE, Andujar JE, Caushaj PF. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum, 2004,47(6) : 825-831.
  • 9Zmora O, Dasailva GM, Gurland B, et al. Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy. Dis Colon Rectum, 2004,47 (10): 1607-1612.

同被引文献25

  • 1于进,王浩龙.新辅助治疗低位进展期直肠癌15例疗效观察[J].国际外科学杂志,2007,34(10):664-666. 被引量:1
  • 2Van Gijn W,Marijnen CA, Nagtegaal ID, et al. Preoperative radio- therapy combined with total mesorectal excision for resectablerectal cancer:12-year-follow-op of the multicentre, randomised controlled TME trial[ J]. Lancet Oncol,2011,12 (6) :575 - 582.
  • 3Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative ra- diotherapy versus selective postoperative chemoradiotherapy in pa- tients with rectal cancer (MRC CR07 and NCIC -CTG C016) :Am- nltieentre, randomised trial [ J]. Lancet,2009,373 ( 96 ) :811 - 820.
  • 4Klautke G,Foitzik T, Ludwig K, et al. Intensified neoadjuvant che- moradiotherapy (CRT) with capecitabine and irinotecan in patients with locally advanced rectal cancer (LARC) : A phase I/II study [J]. JClin Oncol, 2004,22(14S):3693.
  • 5Osti MF,Valeriani M, Masoni L,et al. Neoadjuvant chemoradiation for locally advanced carcinoma of the rectum[ J]. Tumori,2004,90 (3) :303 -309.
  • 6Beddy D, Hyland JM, Winter DC, et al. A simplified tumor regres- sion grade correlates with survival in locally advanced rectal carcino- ma treated with neoadjuvant chemoradiotherapy; J], Ann Surg On- col,2008,15(12) :3471 - 3477.
  • 7Capirci C,Polico C, Mandoliti G. Dislocation of small bowel volume within box pelvic treatment fields, using new" up down table" device [J]. Int J Radiat Oncol Biol Phys,2001,51(2) :465 -473.
  • 8Lee JH,Jang HS,Kim JG,Lee MA,Kim DY,Kim TH,Oh JH,Park SC,Kim SY,Baek JY,Park HC,Kim HC,Nam TK,Chie EK,Jung JH,Oh ST.Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer:pooled analysis of KROG,10-01 and,11-02.Radiother Oncol,2014,113:18-23.
  • 9Kim K,Yeo SG,Yoo BC.Identification of hypoxanthine and phosphoenolpyruvic Acid as serum markers of chemoradiotherapy response in locally advanced rectal cancer.Cancer Res Treat,2015,47:78-89.
  • 10Hur H,Kim NK,Min BS,Baik SH,Lee KY,Koom WS,Ahn JB,Kim H.Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer? Dis Colon Rectum,2014,57:592-601.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部